v3.26.1
COMMITMENTS, CONTINGENCIES AND DEBT (Details)
1 Months Ended 5 Months Ended 12 Months Ended 41 Months Ended
Mar. 12, 2025
USD ($)
Mar. 11, 2025
USD ($)
shares
Jun. 26, 2023
USD ($)
Mar. 20, 2023
USD ($)
Dec. 03, 2020
USD ($)
Apr. 15, 2016
USD ($)
Mar. 22, 2016
USD ($)
Aug. 31, 2022
USD ($)
Dec. 31, 2022
Dec. 31, 2025
USD ($)
installment
item
Dec. 31, 2024
USD ($)
Dec. 31, 2023
Dec. 31, 2025
USD ($)
item
Mar. 05, 2025
USD ($)
$ / shares
shares
May 30, 2023
Jan. 31, 2023
USD ($)
COMMITMENTS, CONTINGENCIES AND DEBT                                
Number of shares in one unit | shares                           1    
Number of warrants in one unit | shares                           2.25    
Loss upon issuance of March 2025 Convertible Notes carried at fair value                   $ 1,198,000            
Fair value                   2,563,000     $ 2,563,000      
Loss on notes receivable                   1,198,000            
Conversion of convertible securities                   916,000            
Proceeds from issuance of common stock from exercise of warrants                   112,000            
Proceeds from issuance of common stock   $ 2,703,000                            
Conversion of units $ 1,366,458                              
Proceeds from Notes Payable                   1,366,000            
Short term lease expenses                   $ 44,000 $ 0          
Number of short term leases | item                   3     3      
Royalty expense                   $ 289,000 293,000          
Research and development expense                   $ 2,878,000 3,266,000          
Research collaboration agreement with johns hopkins university school of medicine                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Percentage of royalty paid                   4.00%            
Annual minimum royalties                   $ 57,500            
Sponsored research agreement                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Sponsored research agreement, amount               $ 1,252,000                
Sponsored research agreement, paid percentage                 68.00% 17.00%   15.00%        
Research and development expense                   $ 50,000 $ 0   $ 1,252,000      
License agreement with multiple entities                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Initial license fee       $ 75,000                        
Annual license fee       $ 50,000                        
License agreement with multiple entities | Maximum                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Royalty expense                   1,350,000            
New sub lease agreement                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Security deposit                               $ 10,000
Securities purchase agreement | Private Placement                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Convertible note                           $ 50,000    
Conversion price | $ / shares                           $ 0.25    
Proceeds from issuance of common stock from exercise of warrants   4,000,000                            
Proceeds from convertible debt   $ 1,316,000                            
Aggregate principal outstanding amount                           $ 1,365,500    
March 2025 Convertible Notes                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Common stock issued under equity line of credit agreement, shares | shares   9,476,837                            
Austin Texas facility                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Renewal term                     54 months          
Lease expires date                     Aug. 31, 2031          
Lease extended description                     with the option to extend the lease for an additional three years          
Shelton Connecticut facility                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Lease term                             5 years  
Amended loan agreement                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Unamortized debt issuance expense                   1,000     1,000      
Debt related to the insurance promissory note                   493,000     $ 493,000      
DECD Loan                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Line of credit, maximum borrowing capacity             $ 4,000,000                  
Debt instrument fixed interest rate             2.00%                  
Maturity date             Apr. 15, 2026                  
Proceeds from Notes Payable         $ 2,000,000 $ 2,000,000                    
Maximum loan forgiveness amount under loan agreement             $ 1,500,000                  
Forgiveness of DECD loan     $ 1,000,000                          
Interest paid for the promissory note                   $ 33,000 $ 36,000          
Percentage of penalty included in loan agreement     5.00%                          
DECD Loan | Loan agreement target employment milestone                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Proceeds from Notes Payable         $ 1,000,000                      
Insurance notes                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Debt instrument fixed interest rate                   8.24% 7.52%   8.24%      
Interest paid for the promissory note                   $ 21,000 $ 23,000          
Aggregate principal outstanding amount                   $ 493,000 $ 614,000   $ 493,000      
Notes 2024                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Number of monthly installments | installment                   9            
Maturity date                   Aug. 01, 2025            
Notes 2025                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Number of monthly installments | installment                   11            
Maturity date                   Oct. 01, 2026            
Convertible Debt                                
COMMITMENTS, CONTINGENCIES AND DEBT                                
Change in fair value of convertible securities $ 170,000                 $ 170,000